| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2018-04-19 |
复牌提示：
2018-04-19 07:55:00 停牌，复牌日期 2018-04-19 08:30:00
|
| 2018-04-02 |
详情>>
股本变动：
变动后总股本790.98万股
|
| 2018-04-02 |
详情>>
业绩披露：
2017年年报每股收益-13.45美元,归母净利润-4057.75万美元,同比去年增长23.48%
|
| 2018-01-17 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2017-11-09 |
详情>>
业绩披露：
2017年三季报(累计)每股收益-0.82美元,归母净利润-3868.46万美元,同比去年增长-2.68%
|
| 2017-08-09 |
详情>>
业绩披露：
2017年中报每股收益-0.79美元,归母净利润-3261.87万美元,同比去年增长-28.29%
|
| 2017-07-06 |
股东大会：
将于2017-07-28召开股东大会
会议内容 ▼▲
- 1.The election of two class III directors, each to serve for a three-year term expiring at the 2020 annual meeting of stockholders, or until his successor has been duly elected and qualified;
2.The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2017;
3.The approval of an amendment to our 2014 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance under the 2014 Stock Incentive Plan and to modify the “evergreen” provision under the 2014 Stock Incentive Plan (the “Plan Amendment”).
4.The approval of an amendment to our Restated Certificate of Incorporation to effect a reverse stock split of our common stock, by a ratio of not less than 1-for-5 and not more than 1-for-20, such ratio and the implementation and timing of such reverse stock split to be determined in the discretion of our board of directors (the “Reverse Stock Split Amendment”);
5.The transaction of any other business that may properly come before the 2017 annual meeting or any adjournment thereof.
|
| 2017-05-10 |
详情>>
业绩披露：
2017年一季报每股收益-0.58美元,归母净利润-2408.01万美元,同比去年增长-87.83%
|
| 2017-03-16 |
详情>>
业绩披露：
2016年年报每股收益-1.66美元,归母净利润-5302.81万美元,同比去年增长29.10%
|
| 2017-03-16 |
详情>>
业绩披露：
2014年年报每股收益-3.12美元,归母净利润-5416.92万美元,同比去年增长-59.91%
|
| 2016-11-14 |
详情>>
业绩披露：
2016年三季报(累计)每股收益-1.3美元,归母净利润-3767.33万美元,同比去年增长34.17%
|
| 2016-08-15 |
详情>>
业绩披露：
2016年中报每股收益-1.04美元,归母净利润-2542.64万美元,同比去年增长31.56%
|
| 2016-05-16 |
详情>>
业绩披露：
2016年一季报每股收益-0.57美元,归母净利润-1282.02万美元,同比去年增长26.93%
|
| 2016-04-29 |
股东大会：
将于2016-06-10召开股东大会
会议内容 ▼▲
- 1.The election of two class II directors, each to serve for a three-year term expiring at the 2019 annual meeting of stockholders;
2.The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2016;
3.The issuance and sale of shares of our common stock to Pharmstandard International S.A. in accordance with Nasdaq listing rules 5635(c) and (d), as described under proposal three (proposal 3) in the accompanying proxy statement;
4.The transaction of any other business that may properly come before the 2016 annual meeting or any adjournment thereof.
|
| 2016-03-30 |
详情>>
业绩披露：
2015年年报每股收益-3.66美元,归母净利润-7478.85万美元,同比去年增长-38.06%
|
| 2014-02-12 |
详情>>
内部人交易：
Nicolette Charles A.等共交易6笔
|